Employers are advocating for changes to the 340B Drug Pricing Program, arguing that it allows hospitals to “buy low and sell high” by purchasing discounted medications and charging insured patients full price.
The post Why Employers Think the 340B Program Needs Reform appeared first on MedCity News.
